Atlas Trials

Predictive Biomarkers of Biological Activity and Efficacy of Nilotinib on ZAK Target in Non-metastatic Colon Cancer

Clinical trial NCT02774512 · WITHDRAWN

Trial details

NCT number
NCT02774512
Sponsor
Institut Bergonié
Status
WITHDRAWN
Phase
Early Phase 1
Study type
INTERVENTIONAL
Colon Cancer
Start date
2016-05-01
Primary completion
2017-11-01
Enrollment
0

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.